Boehringer Ingelheim France SAS
- A10 - Antidiabéticos
- JARDIANCE film-coated tablet 10 mg
- JARDIANCE film-coated tablet 25 mg
- SYNJARDY film-coated tablet 12.5 mg+1 000 mg
- SYNJARDY film-coated tablet 5 mg+1 000 mg
- B01 - Agentes antitrombóticos
- ACTILYSE INJECTABLE/POUR PERFUSION powder and solvent for solution for injection 2 mg
- ACTILYSE powder and solvent for solution for injection 10 mg
- ACTILYSE powder and solvent for solution for injection 20 mg
- ACTILYSE powder and solvent for solution for injection 50 mg
- METALYSE powder and solvent for solution for injection 10 000 IU (50 mg)
- METALYSE powder for solution for injection 5 000 U (25 mg)
- PRADAXA capsule, hard 110 mg
- PRADAXA capsule, hard 150 mg
- PRADAXA capsule, hard 75 mg
- PRADAXA granules 110 mg
- PRADAXA granules 150 mg
- PRADAXA granules 20 mg
- PRADAXA granules 30 mg
- PRADAXA granules 40 mg
- PRADAXA granules 50 mg
- C09 - Agentes activos sobre el sistema renina-angiotensina
- MICARDIS tablet 40 mg
- MICARDIS tablet 80 mg
- MICARDISPLUS tablet 40 mg+12.5 mg
- MICARDISPLUS tablet 80 mg+12.5 mg
- MICARDISPLUS tablet 80 mg+25 mg
- TWYNSTA tablet 40 mg+10 mg
- TWYNSTA tablet 40 mg+5 mg
- TWYNSTA tablet 80 mg+10 mg
- TWYNSTA tablet 80 mg+5 mg
- G04 - Urológicos
- MECIR LP prolonged-release tablet 0.4 mg
- J05 - Antivirales de uso sistémico
- APTIVUS capsule, soft 250 mg
- VIRAMUNE LP prolonged-release tablet 400 mg
- VIRAMUNE oral suspension 50 mg/5 ml
- VIRAMUNE tablet 200 mg
- L01 - Antineoplásicos
- GIOTRIF film-coated tablet 20 mg
- GIOTRIF film-coated tablet 30 mg
- GIOTRIF film-coated tablet 40 mg
- GIOTRIF film-coated tablet 50 mg
- OFEV capsule, soft 100 mg
- OFEV capsule, soft 150 mg
- L04 - Inmunosupresores
- SPEVIGO concentrate for solution for infusion 450 mg
- SPEVIGO EN SERINGUE PREREMPLIE solution for injection 150 mg
- M01 - Antiinflamatorios y antirreumáticos
- MOBIC solution for injection 15 mg/1.5 ml
- MOBIC tablet 15 mg
- MOBIC tablet 7.5 mg
- N04 - Antiparkinsonianos
- SIFROL prolonged-release tablet 0.26 mg
- SIFROL prolonged-release tablet 0.52 mg
- SIFROL prolonged-release tablet 1.05 mg
- SIFROL prolonged-release tablet 2.1 mg
- SIFROL tablet 0.18 mg
- SIFROL tablet 0.7 mg
- R03 - Agentes contra padecimientos obstructivos de las vías respiratorias
- ATROVENT ADULTE EN RÉCIPIENT UNIDOSE nebuliser solution 0.5 mg/1 ml
- ATROVENT ADULTE EN RÉCIPIENT UNIDOSE nebuliser solution 0.5 mg/2 ml
- ATROVENT ENFANT EN RÉCIPIENT UNIDOSE nebuliser solution 0.25 mg/1 ml
- ATROVENT ENFANT EN RÉCIPIENT UNIDOSE nebuliser solution 0.25 mg/2 ml
- ATROVENT pressurised inhalation, suspension 20 µg/dose
- BRONCHODUAL pressurised inhalation, solution 50 µg/dose+20 µg/dose
- SPIOLTO RESPIMAT pressurised inhalation, solution 2.5 µg/dose+2.5 µg/dose
- SPIRIVA inhalation powder, hard capsule 18 µg
- SPIRIVA RESPIMAT pressurised inhalation, solution 2.5 µg/dose
- STRIVERDI RESPIMAT pressurised inhalation, solution 2.5 µg/dose
- V03 - Todos los demás preparados terapéuticos
- PRAXBIND solution for injection 2.5 g/50 ml